NICE issue new guidance on psoriasis10th July 2008
The National Institute for Health and Clinical Excellence (NICE) has issued new guidelines for the use of the anti-TNF drug adalimumab to treat adult patients with plaque psoriasis.
NICE say medical professionals could use the drug only in cases where the psoriasis is deemed to be severe and when other treatments such as ciclosporin or methotrexate have failed to improve the condition. It can also be prescribed where patients have experienced serious side effects from other treatments or those with medical reasons that prevent them from opting for the other options.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: NICE issue new guidance on psoriasis
Author: Mark Nicholls
Article Id: 7457
Date Added: 10th Jul 2008